Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1CNS 1

Conditions

Central Nervous System Neoplasms 8Glioblastoma 6Neuroblastoma 5Brain Neoplasms 5Glioma 4Gliosarcoma 3Astrocytoma 3Teratoma 2Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Rhabdoid Tumor 1Oligodendroglioma 1Neoplasms 1Medulloblastoma 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1

Interventions

Docetaxel 6Radiotherapy 5Filgrastim 3Erlotinib Hydrochloride 3Cetuximab 3Capecitabine 3Bevacizumab 3entrectinib 2Radiotherapy, Intensity-Modulated 2Paclitaxel 2Magnetic Resonance Spectroscopy 2Gemcitabine 2Fluorodeoxyglucose F18 2Cisplatin 2Chemotherapy, Adjuvant 2Acupuncture Therapy 2vandetanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1tipifarnib 1tanespimycin 1spartalizumab 1sargramostim 1oncogene protein E7, Human papillomavirus type 16 1entinostat 1cevimeline 1alectinib 1aldesleukin 1X-Ray Therapy 1Vorinostat 1Trastuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Salivary Gland Neoplasms × Neoadjuvant Therapy × CNS × Clear all
NCT00751816 2015-12-10

Head & Neck Cancer Survivorship: Physical and Functional Status

Vanderbilt University

Completed
23 enrolled
CNSHead & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡